Bausch Health Companies Inc. (BHCN.MX)
Mexico - Mexico Delayed price. Currency in MXN
Add to watchlist
At close: 11:47AM CST
| Previous close | 174.30 |
| Open | 0.00 |
| Bid | 120.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 174.30 - 174.30 |
| 52-week range | 123.90 - 174.30 |
| Volume | |
| Avg. volume | 41 |
| Market cap | 62.018B |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -22.93 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week
As every investor would know, not every swing hits the sweet spot. But you want to avoid the really big losses like the...
- Reuters
Bausch wins US appeal to block Alvogen generic of diarrhea drug
A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029. A Delaware federal court had determined that Alvogen subsidiary Norwich Pharmaceuticals' generic would infringe patents owned by Bausch's Salix Pharmaceuticals.
ZacksWill Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?
Bausch (BHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
© 2024 Yahoo. All rights reserved.